Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Groupon, Inc. (NASDAQ:GRPN), Renewable Energy Group, Inc. (NASDAQ:REGI), Natural Alternatives International (NASDAQ:NAII), TD Ameritrade (NYSE:AMTD)

On Nov. 13, Ocera Therapeutics, Inc. (NASDAQ:OCRX) announced recent business highlights and reported financial results for the quarter ended September 30, 2014. As of September 30, 2014, Ocera had cash, cash equivalents and investments of $55.6 million. Net loss for the three and nine months ended September 30, 2014 was $6.6 million and $17.9 million, respectively. Ocera Therapeutics, Inc. (NASDAQ:OCRX) belongs to Healthcare sector. Its … Continue reading Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Groupon, Inc. (NASDAQ:GRPN), Renewable Energy Group, Inc. (NASDAQ:REGI), Natural Alternatives International (NASDAQ:NAII), TD Ameritrade (NYSE:AMTD)

Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

In June, Esperion Therapeutics Inc. (NASDAQ:ESPR), an Ann Arbor-based early-stage pharmaceutical company, raised $73 million in its IPO. It plans a secondary offering this year, based on trial results of its cholesterol-lowering drug. Esperion Therapeutics Inc (NASDAQ:ESPR) stock performance was -5.04% in last session and finished the day at $14.69. Traded volume was 31,400 shares in the last session and the average volume of the … Continue reading Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

Potbelly Corp. (NASDAQ:PBPB), the hot-sandwich seller that went public nine months ago, dropped the most since its October initial public offering after its annual profit forecast and quarterly sales trailed analysts’ estimates. Potbelly Corp (NASDAQ:PBPB) stock performance was -25.12% in last session and finished the day at $10.97. Traded volume was 7.27million shares in the last session and the average volume of the stock remained … Continue reading Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ:NETE), Lumber Liquidators (NYSE:LL), Ocera Therapeutics Inc (NASDAQ:OCRX)

Registrant and three of its wholly-owned subsidiaries, Reliv, International, Inc (NASDAQ:RELV), Reliv World Corporation and SL Technology, Inc. entered into a Credit Agreement with BMO Harris Bank N.A. (the “Bank”) pursuant to which the Bank agreed to provide certain credit facilities to Registrant, including a Term Loan in the principal amount of $3,481,961 and a revolving credit facility in the amount of $5,000,000. Reliv International, … Continue reading Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera Therapeutics (NASDAQ:OCRX), MediciNova (NASDAQ:MNOV), PTC Therapeutics (NASDAQ:PTCT)

Escalon Medical Corp. (NASDAQ:ESMC) trades at a significant discount to its peer group as the lack of investor (and analyst) following results in the successful “shrink to grow” strategy being ignored. The company is now a pure play with no debt, cash that represents ~20% of the market cap, overlooked tax assets and a significantly lower cash burn rate. Escalon Medical Corp. (NASDAQ:ESMC) stock performance … Continue reading Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year. It has about one year in cash. Last year, it spent $3.5M in R&D and these costs are set to increase as it ramps up the Phase 2 trials for OCR002. Ocera Therapeutics … Continue reading Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)